Galderma signals beyond the news: 59+ signals from 5 sources
The latest Galderma signal on this page is from Sep 29, 2026 (Patents): "Galderma Holding SA's patent output is slowing: 15 grants in the past year, 0 in the past 30 days." The busiest sources: Glassdoor (15+), LinkedIn (15+) and Website changes (15+).
PublicPharmaceutical Manufacturing10,000+ employeesgalderma.comLinkedIn
- Signals
- 59+
- Sources
- 5
- Last 90 days
- 34
- Latest
- Sep 29, 2026
Other signals · latest 10
Latest Galderma signals by source
59+ signals for Galderma across 5 sources.
Patents · Patent pace
Galderma Holding SA's patent output is slowing: 15 grants in the past year, 0 in the past 30 days.
Over the past year Galderma Holding SA received 15 US patent grants; the recent pace (2 in 90 days) is slowing versus its trailing baseline.
- Grants, 12 months
- 15
- Grants, 90 days
- 2
- Grants, 30 days
- 0
- Pace
- Decelerating
Glassdoor · Consistent leadership complaints
Leadership concerns dominate reviews for consumer division and global operations
Two reviews highlight issues with leadership understanding the US market, short-term focus, and constant turnover in management roles, impacting the consumer division's investment and growth.
- Overall rating
- 3.3 of 5
- CEO approval
- 49%
- Reviews read
- 4
- Review window
- Aug 23, 2026 to Sep 7, 2026
Glassdoor · Poor work life balance
Employees work substantial overtime and face challenges with return to office mandates
Multiple reviewers mention employees working beyond standard hours to complete tasks and express concern that mandatory commutes will negatively impact productivity and work-life balance.
- Overall rating
- 3.3 of 5
- CEO approval
- 49%
- Reviews read
- 4
- Review window
- Aug 23, 2026 to Sep 7, 2026
Patents · Patent counsel
Galderma Holding SA uses Foley & Lardner LLP as outside IP counsel.
Foley & Lardner LLP is the attorney of record on Galderma Holding SA's recent US patent work, including a grant in 2026-08.
- Law firm
- Foley & Lardner LLP
- Law firm domain
- foley.com
- Matter date
- Aug 18, 2026
Website changes · Technical update
Galderma reported record first-half 2026 net sales of $3.134 billion and 24.6% year-over-year growth at constant currency.
Added press release: “Galderma reports record first half 2026 net sales of 3.134 billion USD and 24.6% year-on-year growth at constant currency.”
- Page
- /news-archive
Website changes · Marketing shift
Galderma updated its innovation messaging to emphasize a 45-year commitment to dermatology science and innovation.
The page changed “Over the course of our 40+ year heritage” to “Over the course of our 45-year heritage” and changed the positioning from “advancing dermatology” to “advancing the science of dermatology.”
- Page
- /innovation
LinkedIn
Galderma announces EU approval for Restylane Shaype, a new hyaluronic acid injectable for facial shaping.
Restylane® Shaype™ is now approved in the European Union for chin augmentation, the first-and-only bone-mimicking hyaluronic acid injectable for facial shaping. Powered by NASHA HD™ technology, Restylane Shaype is designed for deep injection to build and shape on bone, enabling natural-looking structural...
- Likes
- 99
- Comments
- 1
- Tags
- Product Launch, Medical Research, Pharmaceuticals, Branding
- Initiatives
- launching new hyaluronic acid injectable for facial shaping
LinkedIn
Galderma reports synergistic benefits of Sculptra and Restylane for medication-driven weight loss patients.
A new publication in Clinical, Cosmetic and Investigational Dermatology reinforces the synergistic benefits of Sculptra® and Restylane® in addressing facial sagging and volume loss associated with medication-driven weight loss. The case series report, led by Dr. Luiz Avelar and supported by Galderma, collected...
- Likes
- 259
- Comments
- 7
- Tags
- Medical Research, Pharmaceuticals, Product Development
- Initiatives
- advancing science in aesthetic treatment for weight loss patients
YouTube
She has good genetics She has a great disciplined. 😏✨ Yada Clinic Pattaya
Yada Clinic Pattaya highlights skincare secrets and professional treatments by a Galderma partner.
- Channel
- Yada Clinic Pattaya
- Views
- 14
- Comments
- 0
- Tags
- Skincare, Clinic Services, Galderma Partner
YouTube
Skin To It Season 3: EP29 GLP- 1 Med Face Weight Loss MDWL Uncovered Highlight Reel
Podcast discusses GLP-1 related facial volume loss and aesthetic solutions sponsored by Galderma.
- Channel
- SKIN TO IT Podcast
- Views
- 63
- Comments
- 0
- Tags
- Medical Aesthetics, Dermal Fillers, Skin Health
Showing 10 of 59+ signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Galderma with the Signal API
One POST /v1/companies/enrich call with galderma.com returns Galderma signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "galderma.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Same industry
Other signals at related companies
Questions about Galderma other signals
What signals does Autobound track for Galderma besides news and filings?
What are people saying about Galderma online?
What do employees say about working at Galderma?
Has Galderma been granted patents recently?
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .